NM_021098.3:c.3600C>T
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 2P and 7B. PM2BP4_StrongBP6_ModerateBP7
The NM_021098.3(CACNA1H):c.3600C>T(p.Asp1200Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000129 in 1,552,220 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 33)
Exomes 𝑓: 7.1e-7 ( 0 hom. )
Consequence
CACNA1H
NM_021098.3 synonymous
NM_021098.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.265
Publications
0 publications found
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -5 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 16-1209268-C-T is Benign according to our data. Variant chr16-1209268-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 529666.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-0.265 with no splicing effect.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | ENST00000348261.11 | c.3600C>T | p.Asp1200Asp | synonymous_variant | Exon 17 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
| CACNA1H | ENST00000569107.6 | c.3600C>T | p.Asp1200Asp | synonymous_variant | Exon 17 of 34 | 1 | ENSP00000454990.2 | |||
| CACNA1H | ENST00000711493.1 | c.3600C>T | p.Asp1200Asp | synonymous_variant | Exon 17 of 34 | ENSP00000518778.1 | ||||
| CACNA1H | ENST00000565831.7 | c.3600C>T | p.Asp1200Asp | synonymous_variant | Exon 17 of 34 | 1 | ENSP00000455840.1 | |||
| CACNA1H | ENST00000711450.1 | c.3600C>T | p.Asp1200Asp | synonymous_variant | Exon 17 of 35 | ENSP00000518762.1 | ||||
| CACNA1H | ENST00000564231.6 | c.3600C>T | p.Asp1200Asp | synonymous_variant | Exon 17 of 35 | 1 | ENSP00000457555.2 | |||
| CACNA1H | ENST00000638323.1 | c.3561C>T | p.Asp1187Asp | synonymous_variant | Exon 17 of 35 | 5 | ENSP00000492267.1 | |||
| CACNA1H | ENST00000562079.6 | c.3600C>T | p.Asp1200Asp | synonymous_variant | Exon 17 of 34 | 1 | ENSP00000454581.2 | |||
| CACNA1H | ENST00000711438.1 | c.3561C>T | p.Asp1187Asp | synonymous_variant | Exon 17 of 34 | ENSP00000518754.1 | ||||
| CACNA1H | ENST00000711482.1 | c.3600C>T | p.Asp1200Asp | synonymous_variant | Exon 17 of 36 | ENSP00000518771.1 | ||||
| CACNA1H | ENST00000711485.1 | c.3600C>T | p.Asp1200Asp | synonymous_variant | Exon 17 of 35 | ENSP00000518774.1 | ||||
| CACNA1H | ENST00000711455.1 | c.3600C>T | p.Asp1200Asp | synonymous_variant | Exon 17 of 36 | ENSP00000518768.1 | ||||
| CACNA1H | ENST00000711483.1 | c.3600C>T | p.Asp1200Asp | synonymous_variant | Exon 17 of 35 | ENSP00000518772.1 | ||||
| CACNA1H | ENST00000711456.1 | c.3600C>T | p.Asp1200Asp | synonymous_variant | Exon 17 of 34 | ENSP00000518769.1 | ||||
| CACNA1H | ENST00000621827.2 | n.3600C>T | non_coding_transcript_exon_variant | Exon 17 of 37 | 6 | ENSP00000518766.1 | ||||
| CACNA1H | ENST00000637236.3 | n.3600C>T | non_coding_transcript_exon_variant | Exon 17 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1 | n.3600C>T | non_coding_transcript_exon_variant | Exon 17 of 35 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1 | n.*1513C>T | non_coding_transcript_exon_variant | Exon 17 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*3047C>T | non_coding_transcript_exon_variant | Exon 16 of 34 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711448.1 | n.3600C>T | non_coding_transcript_exon_variant | Exon 17 of 36 | ENSP00000518760.1 | |||||
| CACNA1H | ENST00000711449.1 | n.3600C>T | non_coding_transcript_exon_variant | Exon 17 of 35 | ENSP00000518761.1 | |||||
| CACNA1H | ENST00000711451.1 | n.3600C>T | non_coding_transcript_exon_variant | Exon 17 of 36 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711452.1 | n.3600C>T | non_coding_transcript_exon_variant | Exon 17 of 36 | ENSP00000518764.1 | |||||
| CACNA1H | ENST00000711453.1 | n.3600C>T | non_coding_transcript_exon_variant | Exon 17 of 36 | ENSP00000518765.1 | |||||
| CACNA1H | ENST00000711484.1 | n.3600C>T | non_coding_transcript_exon_variant | Exon 17 of 35 | ENSP00000518773.1 | |||||
| CACNA1H | ENST00000711486.1 | n.3600C>T | non_coding_transcript_exon_variant | Exon 17 of 37 | ENSP00000518775.1 | |||||
| CACNA1H | ENST00000711487.1 | n.3600C>T | non_coding_transcript_exon_variant | Exon 17 of 36 | ENSP00000518776.1 | |||||
| CACNA1H | ENST00000711488.1 | n.3600C>T | non_coding_transcript_exon_variant | Exon 17 of 35 | ENSP00000518777.1 | |||||
| CACNA1H | ENST00000640028.1 | n.*1513C>T | 3_prime_UTR_variant | Exon 17 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*3047C>T | 3_prime_UTR_variant | Exon 16 of 34 | ENSP00000518758.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152132Hom.: 0 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
1
AN:
152132
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 7.14e-7 AC: 1AN: 1400088Hom.: 0 Cov.: 31 AF XY: 0.00000144 AC XY: 1AN XY: 692428 show subpopulations
GnomAD4 exome
AF:
AC:
1
AN:
1400088
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
692428
show subpopulations
African (AFR)
AF:
AC:
1
AN:
31992
American (AMR)
AF:
AC:
0
AN:
36846
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25232
East Asian (EAS)
AF:
AC:
0
AN:
36236
South Asian (SAS)
AF:
AC:
0
AN:
80552
European-Finnish (FIN)
AF:
AC:
0
AN:
40102
Middle Eastern (MID)
AF:
AC:
0
AN:
5702
European-Non Finnish (NFE)
AF:
AC:
0
AN:
1085156
Other (OTH)
AF:
AC:
0
AN:
58270
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152132Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74306 show subpopulations
GnomAD4 genome
AF:
AC:
1
AN:
152132
Hom.:
Cov.:
33
AF XY:
AC XY:
0
AN XY:
74306
show subpopulations
African (AFR)
AF:
AC:
1
AN:
41452
American (AMR)
AF:
AC:
0
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5174
South Asian (SAS)
AF:
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
AC:
0
AN:
67990
Other (OTH)
AF:
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Jul 18, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.